Sharon G Cox1, A Davidson2, J Thomas2, A Brooks2, J Hewitson2, A Numanoglu2, A J W Millar2. 1. Divisions of Paediatric Surgery, Cardiothoracic Surgery, Anaesthetics and Haematology/Oncology, University of Cape Town, Red Cross War Memorial Children's Hospital, Klipfontein Road, Rondebosch, Cape Town, 7700, South Africa. sharon.cox@uct.ac.za. 2. Divisions of Paediatric Surgery, Cardiothoracic Surgery, Anaesthetics and Haematology/Oncology, University of Cape Town, Red Cross War Memorial Children's Hospital, Klipfontein Road, Rondebosch, Cape Town, 7700, South Africa.
Abstract
PURPOSE: To review demographics, effect of preoperative chemotherapy on tumour thrombus, imaging, operative strategy, and outcomes of 12 patients presenting with intracardiac extension of Wilms tumour thrombus. METHODS: A retrospective audit was undertaken on patients with intracardiac extension of Wilms tumour. Patients were identified from the oncology database and information obtained on clinical presentation, stage, preoperative treatment, surgical procedures and complications, histology, and survival status. Ethics approval was obtained from the University of Cape Town Human Research Ethics Committee. RESULTS: From 1984 to 2016, 337 children with Wilms tumour were treated. Twelve (3.6%) had intracardiac extension of tumour thrombus, nine into the right atrium, and three into the right ventricle. Ultrasound, computerized tomography, magnetic resonance imaging, and echocardiograms were used to assess thrombus level. Patients were staged as stage III(8) and IV(4). All patients received preoperative chemotherapy. Thrombus retracted from the heart in two cases. One patient died preoperatively. Eleven underwent laparotomy, median sternotomy, and cardiopulmonary bypass (CPB). Four underwent cavectomy. Five required cavoatrial patches. Thrombus extending into the hepatic veins was extracted in five patients. There was one intraoperative complication and one perioperative death. Thrombus histology showed viable tumour in 9 of 11 patients. Three patients died of progressive disease. Seven patients are currently disease free. CONCLUSION: A combination of imaging is required to determine thrombus extent, and this facilitates surgical planning. Preoperative chemotherapy may cause thrombus regression, thus avoiding CPB. CPB offers appropriate conditions for safe tumour thrombus excision. Full management in centres with appropriately experienced staff and facilities for CPB is recommended.
PURPOSE: To review demographics, effect of preoperative chemotherapy on tumour thrombus, imaging, operative strategy, and outcomes of 12 patients presenting with intracardiac extension of Wilms tumour thrombus. METHODS: A retrospective audit was undertaken on patients with intracardiac extension of Wilms tumour. Patients were identified from the oncology database and information obtained on clinical presentation, stage, preoperative treatment, surgical procedures and complications, histology, and survival status. Ethics approval was obtained from the University of Cape Town Human Research Ethics Committee. RESULTS: From 1984 to 2016, 337 children with Wilms tumour were treated. Twelve (3.6%) had intracardiac extension of tumour thrombus, nine into the right atrium, and three into the right ventricle. Ultrasound, computerized tomography, magnetic resonance imaging, and echocardiograms were used to assess thrombus level. Patients were staged as stage III(8) and IV(4). All patients received preoperative chemotherapy. Thrombus retracted from the heart in two cases. One patient died preoperatively. Eleven underwent laparotomy, median sternotomy, and cardiopulmonary bypass (CPB). Four underwent cavectomy. Five required cavoatrial patches. Thrombus extending into the hepatic veins was extracted in five patients. There was one intraoperative complication and one perioperative death. Thrombus histology showed viable tumour in 9 of 11 patients. Three patients died of progressive disease. Seven patients are currently disease free. CONCLUSION: A combination of imaging is required to determine thrombus extent, and this facilitates surgical planning. Preoperative chemotherapy may cause thrombus regression, thus avoiding CPB. CPB offers appropriate conditions for safe tumour thrombus excision. Full management in centres with appropriately experienced staff and facilities for CPB is recommended.
Authors: Yusuf Abdullah; Jonathan Karpelowsky; Alan Davidson; Jenny Thomas; Andre Brooks; John Hewitson; Alp Numanoglu; Sharon Cox; Alastair J W Millar Journal: J Pediatr Surg Date: 2013-02 Impact factor: 2.545
Authors: R C Shamberger; M L Ritchey; G M Haase; T L Bergemann; T Loechelt-Yoshioka; N E Breslow; D M Green Journal: Ann Surg Date: 2001-07 Impact factor: 12.969
Authors: Lilian M Cristofani; Ricardo J Duarte; Maria T Almeida; Vicente Odone Filho; Joao G Maksoud; Miguel Srougi Journal: Int Braz J Urol Date: 2007 Sep-Oct Impact factor: 1.541
Authors: M L Ritchey; K C Pringle; N E Breslow; J Takashima; J Moksness; C W Zuppan; J B Beckwith; P R Thomas; P P Kelalis Journal: Ann Surg Date: 1994-11 Impact factor: 12.969
Authors: Mayara Caroline Amorim Fanelli; José Cícero Stocco Guilhen; Alexandre Alberto Barros Duarte; Fernanda Kelly Marques de Souza; Monica Dos Santos Cypriano; Eliana Maria Monteiro Caran; Henrique Manoel Lederman; Maria Teresa de Seixas Alves; Simone de Campos Vieira Abib Journal: Front Pediatr Date: 2022-01-04 Impact factor: 3.418